17685.00HUF0.00%Mkt Cap: 49.10B $P/E: —2d ago
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates thro…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap49.10B $
Enterprise Value49.20B $
Revenue (TTM)128.23M $
Gross Profit75.68M $
Net Income (TTM)-10.23M $
Revenue/Share0.1305 USD
Last Price17685.00 HUF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees87.8K
CountryHU
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG4.66
EV/EBITDA1717.91
EV/Revenue383.64
P/S382.90
P/B587.29
EPS (TTM)-641.97
EPS (Forward)—
52W Range
8988.0090% of range18700.00
52W High18700.00 HUF
52W Low8988.00 HUF
Profitability
Gross Margin58.76%
Oper. Margin9.19%
EBITDA Margin22.33%
Profit Margin-7.94%
ROE-13.95%
ROA-3.46%
Growth
Revenue Growth1.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF16.76M $
CapEx (TTM)7.03M $
FCF Margin14.46%
FCF Yield0.04%
Net Debt94.25M $
Net Debt/EBITDA3.29
Balance Sheet
Debt/Equity1.40
Current Ratio1.04
Quick Ratio0.67
Book Value/Sh30.11 HUF
Cash/Share5.173 HUF
Dividends
Fwd Div Rate40.04 HUF
Trail. Div Rate0.1100 HUF
Div. Yield0.23%
5Y Avg Yield—
Payout Ratio163.27%
Ex-Div DateApr 27, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.982.42M
Float982.42M
Insiders0.01%
Institutions61.47%
Technical
SMA 5016715.30 (+5.8%)
SMA 20014935.81 (+18.4%)
Beta0.83
S&P 52W Chg18.16%
Avg Vol (30d)85
Avg Vol (10d)5
Technical Indicators
RSI (14)77.2
MACD554.1222
MACD Signal2.8828
MACD Hist.+551.2394
BB Upper17954.52 HUF
BB Middle14600.50 HUF
BB Lower11246.48 HUF
BB Width45.94%
ATR (14)384.61 HUF
Vol Ratio (20d)0.00x